Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Sign Up to like & getrecommendations! Published in 2020 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-020-06981-3
Abstract: Ischaemic stroke and systemic embolism are the major potentially preventable complications of atrial fibrillation (AF) leading to severe morbidity and mortality. Anticoagulation using vitamin K antagonists (VKA) or non-vitamin K oral anticoagulants (NOACs) is mandatory… read more here.
Keywords: cardiology; anticoagulants stroke; atrial fibrillation; stroke prevention ... See more keywords
Direct Oral Anticoagulants for Stroke Prevention in Special Populations: Beyond the Clinical Trials
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11010131
Abstract: Currently, direct oral anticoagulants (DOACs) are the first-line anticoagulant strategy in patients with non-valvular atrial fibrillation (NVAF). They are characterized by a more favorable pharmacological profile than warfarin, having demonstrated equal efficacy in stroke prevention… read more here.
Keywords: anticoagulants stroke; direct oral; stroke prevention; oral anticoagulants ... See more keywords